Cantor Fitzgerald Downgrades Tonix Pharma (TNXP) to Hold
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Cantor Fitzgerald downgraded Tonix Pharma (NASDAQ: TNXP) from Buy to Hold with a price target of $1.00 (from $5.00).
Shares of Tonix Pharma closed at $0.92 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Credit Suisse Downgrades Time Warner (TWX) to Neutral Following Takeover
- Netflix (NFLX) PT Raised to $140 at Guggenheim
- Amazon (AMZN) PT Raised to $1050 at Goldman Sachs Into Q3 Print
Create E-mail Alert Related CategoriesAnalyst PT Change, Downgrades
Related EntitiesCantor Fitzgerald
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!